Clearpoint Neuro Inc. (NASDAQ:CLPT)

Thursday, August 13, 2020 | Web News
Clearpoint Neuro Inc. (NASDAQ:CLPT) ($4.04; $62.0M market cap) a leading platform neurosurgery company, announced Q2 2020 results:...
Wednesday, March 11, 2020 | Web News
Please join us as the CEO of Clearpoint Neuro Inc. (NASDAQ:CLPT), Joseph Burnett, discusses his company with GeoInvesting and meeting attendees. Participant Q&...
Friday, February 14, 2020 | Web News
ClearPoint Neuro (NASDAQ: CLPT) ($5.61; $85.5M market cap) (old symbol MRIC) a leading platform neurosurgery company, announced...
See All Research...
Monday, April 26, 2021, 9:43AM

1. Pitches on #AvoidingTheCrowd, Planet MicrocapVirtual Showcase, April 21, 2021 Paul Andreola @PaulAndreola?, $VPI.V $VPRIF Richard Howe @stockspinoffss?, $MDP.V $MEDXF Kelvin Seetoh @SlingshotCap?, $CLPT Andrew Walker @AndrewRangeley, $WOW

Monday, January 25, 2021, 9:27AM
Quick review of last night's weekly wrap up: - Article on $FTDL is available and we consider it a potential #MultiBagger - Reiterating a shift of a few model portfolio holdings: Closed $CLPT long, Removed $IEC from top 5 faves and replaced w/ $IAIC
Tuesday, January 19, 2021, 10:15AM
Closing out our long position in $CLPT. Shares have had a strong run over the last year and are up over 300% since our initial disclosure in Dec 2019. With a P/Sales of near 20 on 2021 revs we feel it is fairly valued.
See All Alerts...
Clearpoint Neuro Inc, formerly MRI Interventions, Inc., MRI Interventions, Inc. is a medical device company. The Company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain and heart under direct, intra-procedural magnetic resonance imaging (MRI) guidance. It has two product platforms: ClearPoint system, which is used to perform minimally invasive surgical procedures in the brain and ClearTrace system, which is under development, to be used to perform minimally invasive surgical procedures in the heart. Its ClearPoint system is a neuro-navigation system designed for placing catheters and electrodes to treat a range of neurological diseases and conditions and for performing biopsies. Its ClearTrace system is designed to deliver catheter-based therapies to treat certain cardiac diseases. Both systems utilize intra-procedural MRI to guide the procedures.

Web site:

Last updated February 13, 2020